{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:49:18Z","timestamp":1761166158739,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.anndiagpath.2021.151767","type":"journal-article","created":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T05:17:06Z","timestamp":1622870226000},"page":"151767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["From the archives of MD Anderson Cancer Center: Concurrent BCR-ABL1 and CRLF2 rearrangements in B-lymphoblast phase of chronic myeloid leukemia"],"prefix":"10.1016","volume":"53","author":[{"given":"Beenu","family":"Thakral","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergej","family":"Konoplev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.anndiagpath.2021.151767_bb0005","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151767_bb0010","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ajh.24275","article-title":"Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring","volume":"91","author":"Jabbour","year":"2016","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2021.151767_bb0015","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/leu.2016.6","article-title":"Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy","volume":"30","author":"Chen","year":"2016","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.anndiagpath.2021.151767_bb0020","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/leu.2016.231","article-title":"Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy","volume":"31","author":"Chen","year":"2017","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.anndiagpath.2021.151767_bb0025","doi-asserted-by":"crossref","first-page":"e490","DOI":"10.1038\/bcj.2016.96","article-title":"Clinical significance of trisomy 8 that emerges during therapy in chronic myeloid leukemia","volume":"6","author":"Wang","year":"2016","journal-title":"Blood Cancer J"},{"issue":"22","key":"10.1016\/j.anndiagpath.2021.151767_bb0030","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1182\/blood-2016-01-690230","article-title":"Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy","volume":"127","author":"Wang","year":"2016","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.anndiagpath.2021.151767_bb0035","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1182\/blood-2009-09-245944","article-title":"Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic\/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia","volume":"115","author":"Harvey","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151767_bb0040","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/ajcp\/aqx005","article-title":"CRLF2-positive B-cell acute lymphoblastic leukemia in adult patients: a single-institution experience","volume":"147","author":"Konoplev","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"19","key":"10.1016\/j.anndiagpath.2021.151767_bb0045","doi-asserted-by":"crossref","first-page":"7347","DOI":"10.1158\/0008-5472.CAN-10-1528","article-title":"CRLF2 and JAK2 in B-progenitor acute lymphoblastic leukemia: a novel association in oncogenesis","volume":"70","author":"Roll","year":"2010","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"10.1016\/j.anndiagpath.2021.151767_bb0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1615\/CritRevOncog.v16.i1-2.30","article-title":"Understanding the biology of CRLF2-overexpressing acute lymphoblastic leukemia","volume":"16","author":"Tasian","year":"2011","journal-title":"Crit Rev Oncog"},{"issue":"5","key":"10.1016\/j.anndiagpath.2021.151767_bb0055","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151767_bb0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","article-title":"A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study","volume":"10","author":"Den Boer","year":"2009","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.anndiagpath.2021.151767_bb0065","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.anndiagpath.2021.151767_bb0070","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3324\/haematol.2013.085175","article-title":"Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features","volume":"98","author":"Schwab","year":"2013","journal-title":"Haematologica"},{"issue":"14","key":"10.1016\/j.anndiagpath.2021.151767_bb0075","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1200\/JCO.2013.51.3242","article-title":"IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcome","volume":"32","author":"Russell","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151767_bb0080","doi-asserted-by":"crossref","first-page":"e514","DOI":"10.3324\/haematol.2016.161000","article-title":"Co-occurrence of CRLF2-rearranged and Ph+ acute lymphoblastic leukemia: a report of four cases","volume":"102","author":"Jain","year":"2017","journal-title":"Hematologica"},{"key":"10.1016\/j.anndiagpath.2021.151767_bb0085","doi-asserted-by":"crossref","first-page":"e26539","DOI":"10.1002\/pbc.26539","article-title":"Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood","volume":"64","author":"Schmah","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.anndiagpath.2021.151767_bb0090","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood-2016-07-726588","article-title":"Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults","volume":"129","author":"Jain","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2021.151767_bb0095","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3390\/ijms21062193","article-title":"The current genomic and molecular landscape of Philadelphia-like acute lymphoblastic leukemia","volume":"21","author":"Shiraz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.anndiagpath.2021.151767_bb0100","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.beha.2018.09.003","article-title":"Why and how to treat Ph-like ALL?","volume":"31","author":"Roberts","year":"2018","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.anndiagpath.2021.151767_bb0105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.leukres.2015.11.018","article-title":"CRLF2 overexpression identifies an unfavorable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities","volume":"41","author":"Chiaretti","year":"2016","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151767_bb0110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3324\/haematol.2015.136366","article-title":"Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis","volume":"102","author":"Herold","year":"2017","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151767_bb0115","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.2016.69.0073","article-title":"High frequency and poor outcome of Philadelphia chromosome-like acute lymphoblastic leukemia in adults","volume":"35","author":"Roberts","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151767_bb0120","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1073\/pnas.0911726107","article-title":"Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia","volume":"107","author":"Yoda","year":"2010","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421000678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421000678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:33:19Z","timestamp":1761078799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913421000678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":24,"alternative-id":["S1092913421000678"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151767","relation":{},"ISSN":["1092-9134"],"issn-type":[{"type":"print","value":"1092-9134"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From the archives of MD Anderson Cancer Center: Concurrent BCR-ABL1 and CRLF2 rearrangements in B-lymphoblast phase of chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151767","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151767"}}